Christopher R. Cline

CHIEF FINANCIAL OFFICER

CHIEF FINANCIAL OFFICER at Travere Therapeutics, Inc., filing insider transactions between 2026-09-02 and 2026-09-15.

Total Purchases

—

0 transactions

Total Sales

$3.2M

5 transactions

Companies Traded

5 total filings

Active Since

2026-09-02

Last: 2026-09-15

Companies

Travere Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-09-15	TVTX	Sale	1,900	$63.69	$121K	87.9K	SEC ↗
2026-09-15	TVTX	Sale	20.7K	$62.61	$1.3M	89.8K	SEC ↗
2026-09-15	TVTX	Sale	27.5K	$62.00	$1.7M	110.5K